Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Szer

Showing results (71-80 of 195) with videos related to

Pageof 20
Sort By:
Australian and New Zealand Journal of Medicine|June 27, 2000
The addition of allogeneic peripheral blood-derived progenitor cells to bone marrow for transplantation: results of a randomised clinical trialJ Szer, D J Curtis, P G Bardy, et al.
Internal Medicine Journal|August 2, 2001
Chemotherapy and granulocyte colony stimulating factor-mobilized blood cell infusion followed by interferon-alpha for relapsed malignancy after allogeneic bone marrow transplantationA Grigg, K Kannan, A P Schwarer, et al.
Bone Marrow Transplantation|April 10, 1999
Fludarabine-based non-myeloablative chemotherapy followed by infusion of HLA-identical stem cells for relapsed leukaemia and lymphomaA Grigg, P Bardy, K Byron, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 5, 2002
Fludarabine and mitoxantrone: effective and well-tolerated salvage therapy in relapsed indolent lymphoproliferative disordersJ F Seymour, A P Grigg, J Szer, et al.
Internal Medicine Journal|July 3, 2015
Oral chronic graft-versus-host disease in Australia: clinical features and challenges in managementK Hull, I Kerridge, S Avery, et al.
Bone Marrow Transplantation|July 1, 1995
Chronic airflow obstruction in long-term survivors of allogeneic bone marrow transplantationD J Curtis, A Smale, F Thien, et al.
British Journal of Haematology|April 1, 1991
The toxicity of busulphan and cyclophosphamide as the preparative regimen for bone marrow transplantationM Morgan, A Dodds, K Atkinson, et al.
British Journal of Cancer|November 1, 1992
Prior chemotherapy does not prevent effective mobilisation by G-CSF of peripheral blood progenitor cellsE DeLuca, W P Sheridan, D Watson, et al.
Bone Marrow Transplantation|May 16, 2017
Pre-transplant ferritin, albumin and haemoglobin are predictive of survival outcome independent of disease risk index following allogeneic stem cell transplantationL Chee, M Tacey, B Lim, et al.
Bone Marrow Transplantation|January 12, 2010
Etoposide induces more severe mucositis than CY when added to TBI as conditioning in allograft recipients receiving CsA and MTXR Hoyt, D S Ritchie, A Wirth, et al.
Pageof 20

Showing results (71-80 of 195) with videos related to

Sort By:
Pageof 20
Australian and New Zealand Journal of Medicine|June 27, 2000
The addition of allogeneic peripheral blood-derived progenitor cells to bone marrow for transplantation: results of a randomised clinical trialJ Szer, D J Curtis, P G Bardy, et al.
Internal Medicine Journal|August 2, 2001
Chemotherapy and granulocyte colony stimulating factor-mobilized blood cell infusion followed by interferon-alpha for relapsed malignancy after allogeneic bone marrow transplantationA Grigg, K Kannan, A P Schwarer, et al.
Bone Marrow Transplantation|April 10, 1999
Fludarabine-based non-myeloablative chemotherapy followed by infusion of HLA-identical stem cells for relapsed leukaemia and lymphomaA Grigg, P Bardy, K Byron, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 5, 2002
Fludarabine and mitoxantrone: effective and well-tolerated salvage therapy in relapsed indolent lymphoproliferative disordersJ F Seymour, A P Grigg, J Szer, et al.
Internal Medicine Journal|July 3, 2015
Oral chronic graft-versus-host disease in Australia: clinical features and challenges in managementK Hull, I Kerridge, S Avery, et al.
Bone Marrow Transplantation|July 1, 1995
Chronic airflow obstruction in long-term survivors of allogeneic bone marrow transplantationD J Curtis, A Smale, F Thien, et al.
British Journal of Haematology|April 1, 1991
The toxicity of busulphan and cyclophosphamide as the preparative regimen for bone marrow transplantationM Morgan, A Dodds, K Atkinson, et al.
British Journal of Cancer|November 1, 1992
Prior chemotherapy does not prevent effective mobilisation by G-CSF of peripheral blood progenitor cellsE DeLuca, W P Sheridan, D Watson, et al.
Bone Marrow Transplantation|May 16, 2017
Pre-transplant ferritin, albumin and haemoglobin are predictive of survival outcome independent of disease risk index following allogeneic stem cell transplantationL Chee, M Tacey, B Lim, et al.
Bone Marrow Transplantation|January 12, 2010
Etoposide induces more severe mucositis than CY when added to TBI as conditioning in allograft recipients receiving CsA and MTXR Hoyt, D S Ritchie, A Wirth, et al.
Pageof 20